Psyence Biomedical Ltd. Common Shares

PBM XNAS

Market Cap

9.1M

Short interest (May 15)

3.1%

Net Short (Jun 03 ): -0.6%

Borrow Fee

89.22%

↓ 57.7%

Available Shares

300K

↑ 122.9%

Price Chart

Company Overview

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Company Info

Exchange: NASDAQ
CIK: 0001985062
Asset Type: CS

Market Data

Market Cap: $9,058,562
Employees: 12
Status: Active

Short Interest

Current Borrow Fee 89.22%
Range: 89.22% - 89.79%
Available Shares 300K
Range: 200K - 250K

Recent Changes

Fee Change: ↓ 21.2%
Available Change: ↓ 9.1%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime